• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUTOGEN MEDICAL GMBH DURAFELX; BOVINE PERICARDIUM DURAL GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUTOGEN MEDICAL GMBH DURAFELX; BOVINE PERICARDIUM DURAL GRAFT Back to Search Results
Lot Number NZ18450004
Device Problem Degraded (1153)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 09/26/2019
Event Type  Injury  
Manufacturer Narrative
The xenograft was not available for return.Therefore, a comprehensive records re-review of manufacturing records, sterilization run reports, quality control/assurance reviews and release, and complaint database for related complaints associated with the lot was conducted.There were no departures noted during records re-review for lot nz18450004.All bovine pericardium implants undergo a validated sterilization method (tutoplast® which includes terminal sterilization by gamma irradiation after packaging.Manufacturing records indicate that all xenografts implants manufactured from this lot met all specifications and release criteria prior to distribution.To date, rti has manufactured and distributed a total of 10 xenograft implants from the lot without related complaints.Additional information is needed to better understand and possibly explain the complications reported, including information regarding the suture procedure and suture material utilized, whether the membrane was fixed under tension, membrane rehydration procedure prior to use, and whether the patient has an allergy to bovine collagen and/or bovine material.
 
Event Description
Rti surgical, inc (rti) received an adverse event from integra lifesciences on 10/02/19.The reported complaint indicated that a patient underwent implantation of a duraflex (bovine pericardium membrane) graft on (b)(6) 2019.On (b)(6) 2019, the patient was taken back to the operating room due to a hemorrhage.At that time, the surgeon noted that the duraflex graft had disintegrated.The sutures were still present, but a film was left behind with no sign of the graft.Attempts have been made to obtain additional patient clinical information.To date, rti has not received any additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURAFELX
Type of Device
BOVINE PERICARDIUM DURAL GRAFT
Manufacturer (Section D)
TUTOGEN MEDICAL GMBH
industriestr 6
neunkirchen am brand, 91077
GM  91077
Manufacturer Contact
leila kelly
11621 research circle
alachua, FL 32615
3864188888
MDR Report Key9272884
MDR Text Key166195602
Report Number3002719998-2019-00021
Device Sequence Number1
Product Code GXQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Type of Report Initial
Report Date 11/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Lot NumberNZ18450004
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/02/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-